{
    "Trade/Device Name(s)": [
        "Biophen Protein C 5",
        "Biophen Protein C 2.5",
        "Biophen Protein C 5 & 2.5",
        "Biophen @ Protein C 2.5 & 5"
    ],
    "Submitter Information": "HyphenBiomed",
    "510(k) Number": "K050365",
    "Predicate Device Reference 510(k) Number(s)": [
        "K922201"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "February 14, 2005",
    "Summary Letter Received Date": "February 15, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7290"
    ],
    "Regulation Name(s)": [
        "Factor deficiency test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Protein C activity"
    ],
    "Specimen Type(s)": [
        "Human citrated plasma",
        "Human plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromogenic assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Biophen Protein C chromogenic assay for measuring Protein C activity in human citrated plasma.",
    "Indications for Use Summary": "Chromogenic assay for measuring Protein C Activity in human citrated plasma using a manual or automated method.",
    "fda_folder": "Hematology"
}